<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In patients with low-grade lymphoid <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, severe <z:hpo ids='HP_0001875'>neutropenia</z:hpo> due to massive bone marrow infiltration of lymphocytes increases the risk of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, especially after myelosuppressive chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>Three patients (two with <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> and one with follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) with massive bone marrow infiltration and <z:hpo ids='HP_0001875'>neutropenia</z:hpo> not caused by short-term effects of chemotherapy, were treated with G-CSF for five two-week periods, to find out if the <z:hpo ids='HP_0001875'>neutropenia</z:hpo> was reversible </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three patients initially responded to G-CSF with an increase of neutrophil counts into the <z:mpath ids='MPATH_458'>normal</z:mpath> range or above </plain></SENT>
<SENT sid="3" pm="."><plain>In one patient, G-CSF administered after a subsequent course of myelosuppressive chemotherapy apparently prevented severe chemotherapy-induced <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Retreatment of a previous responder in a later, preterminal stage of the disease produced very little response in terms of neutrophil counts </plain></SENT>
<SENT sid="5" pm="."><plain>G-CSF can increase peripheral blood neutrophil counts to <z:mpath ids='MPATH_458'>normal</z:mpath> levels in patients with severe <z:hpo ids='HP_0001875'>neutropenia</z:hpo> induced by lymphoid bone marrow infiltration </plain></SENT>
</text></document>